BioCentury
ARTICLE | Financial News

CRISPR diagnostics play Mammoth raises $23M series A

August 3, 2018 5:19 PM UTC

Mammoth Biosciences (San Francisco, Calif.) raised $23 million on July 31 in a series A round led by Mayfield Partners, with participation from fellow seed investors NFX and 8VC.

Co-founder and CEO Trevor Martin told BioCentury the funds will enable Mammoth to bring its first CRISPR-based diagnostic to market. He declined to disclose specific diagnostic indications or provide a development timeline...

BCIQ Company Profiles

Mammoth Biosciences Inc.